Sulfonamides Market , By Product Type (Sulfadiazine, Sulfamethoxazole, Sulfasalazine, Sulfisoxazole, Sulfathiazole, Sulfapyridine, Sulfacetamide, and Others (fixed-dose sulfonamide combinations)),By Route of Administration (Oral, Parenteral, and Topical), By Application(Urinary tract infections, Respiratory tract infections, Gastrointestinal infections, Ophthalmic infections, Skin and soft-tissue infections, HIV-associated opportunistic infections, and Veterinary infections),By Class (Short-acting sulfonamides, Intermediate-acting sulfonamides, Long-acting sulfonamides, and Combination sulfonamides (TMP-SMX) ), By Formulation (Tablets, Capsules, Suspensions, Injectables, Ointments and creams, and Ophthalmic solutions), By Prescription Type (Prescription-Based and Over-the-Counter (OTC)), By Status (Branded/Patented Drugs and Generic Drugs), By End User (Hospitals, Clinics, and Veterinary hospitals and clinics), By Distribution Channel (Hospital pharmacies, Retail pharmacies, and Online pharmacies), By Geography ( North America, Latin America, Europe, Asia Pacific, Middle East, Africa)
선택하다 귀사의 비즈니스 요구 사항에 맞는 라이센스 유형
US$ 2,200
이천이백 달러
단일 사용자 라이센스
( 전체 보고서 )
US$ 4,500
US$ 3,000
Three thousand dollars
자주 구매되는 상품
다중 사용자 라이센스
(전체 보고서)
US$ 7,000
US$ 5,000
Five thousand dollars
기업 사용자 라이센스
(전체 보고서)
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
우리의 고객